1
|
Suh MA, Atashili J, Fuh EA and Eta VA:
Breast self-examination and breast cancer awareness in women in
developing countries: a survey of women in Buea, Cameroon. BMC Res
Notes. 5:6272012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Yilmaz YE, Lawless JF, Andrulis IL and
Bull SB: Insights from mixture cure modeling of molecular markers
for prognosis in breast cancer. J Clin Oncol. 31:2047–2054. 2013.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Park Y, Chang M, Lee S, et al:
Heterogeneity of triple negative breast cancer (TNBC): TNBC might
be divided into two or more subgroups by clinicopathologic
findings. Cancer Res. 69:(Abstract 6032; Suppl 24). 2009.
View Article : Google Scholar
|
4
|
Kohno D and Yada T: Arcuate NPY neurons
sense and integrate peripheral metabolic signals to control
feeding. Neuropeptides. 46:315–319. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Memminger M, Keller M, Lopuch M, et al:
The neuropeptide y y(1) receptor: a diagnostic marker? Expression
in mcf-7 breast cancer cells is down-regulated by antiestrogens in
vitro and in xenografts. PLoS One. 7:e510322012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Wolff AC, Hammond ME, Schwartz JN, et al:
American Society of Clinical Oncology/College of American
Pathologists guideline recommendations for human epidermal growth
factor receptor 2 testing in breast cancer. J Clin Oncol.
25:118–145. 2007. View Article : Google Scholar
|
8
|
Rahbari NN, Bork U, Motschall E, et al:
Molecular detection of tumor cells in regional lymph nodes is
associated with disease recurrence and poor survival in
node-negative colorectal cancer: a systematic review and
meta-analysis. J Clin Oncol. 30:60–70. 2012. View Article : Google Scholar
|
9
|
Liu L, Liao GQ, He P, Zhu H, et al:
Detection of circulating cancer cells in lung cancer patients with
a panel of marker genes. Biochem Biophys Res Commun. 372:756–760.
2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kavak E, Ünlü M, Nistér M and Koman A:
Meta-analysis of cancer gene expression signatures reveals new
cancer genes, SAGE tags and tumor associated regions of
co-regulation. Nucleic Acids Res. 38:7008–7021. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Blackhall F, Peters S, Kerr KM, et al:
Biomarkers. Ann Onc. 23:ix73–ix94. 2012. View Article : Google Scholar
|
12
|
Higuchi H: Molecular analysis of central
feeding regulation by neuropeptide Y (NPY) neurons with NPY
receptor small interfering RNAs (siRNAs). Neurochem Int.
61:936–941. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kiyokawa M, Matsuzaki T, Iwasa T, et al:
Neuropeptide Y mediates orexin A-mediated suppression of pulsatile
gonadotropin-releasing hormone secretion in ovariectomized rats. J
Med Invest. 58:11–18. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Körner M, Waser B and Reubi JC: High
expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
Clin Cancer Res. 14:5043–5049. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lu C, Tilan JU, Everhart L, et al:
Dipeptidyl peptidases as survival factors in Ewing sarcoma family
of tumors: implications for tumor biology and therapy. J Biol Chem.
286:27494–27505. 2011. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ruscica M, Dozio E, Boghossian S, et al:
Activation of the Y1 receptor by neuropeptide Y regulates the
growth of prostate cancer cells. Endocrinology. 147:1466–1473.
2006. View Article : Google Scholar
|
17
|
Körner M, Waser B and Reubi JC: High
expression of neuropeptide y receptors in tumors of the human
adrenal gland and extra-adrenal paraganglia. Clin Cancer Res.
10:8426–8433. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Reubi JC, Gugger M, Waser B and Schaer JC:
Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas
as targets. Cancer Res. 61:4636–4641. 2001.PubMed/NCBI
|
19
|
Amlal H, Faroqui S, Balasubramaniam A and
Sheriff S: Estrogen up-regulates neuropeptide Y Y1 receptor
expression in a human breast cancer cell line. Cancer Res.
66:3706–3714. 2006. View Article : Google Scholar : PubMed/NCBI
|
20
|
Sheriff S, Ali M, Yahya A, et al:
Neuropeptide Y Y5 receptor promotes cell growth through
extracellular signal-regulated kinase signaling and cyclic AMP
inhibition in a human breast cancer cell line. Mol Cancer Res.
8:604–614. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Lennon S, Barton C, Banken L, et al:
Utility of serum HER2 extracellular domain assessment in clinical
decision making: pooled analysis of four trials of trastuzumab in
metastatic breast cancer. J Clin Oncol. 27:1685–1693. 2009.
View Article : Google Scholar : PubMed/NCBI
|